{"id":7393,"date":"2026-03-17T15:52:00","date_gmt":"2026-03-17T15:52:00","guid":{"rendered":"https:\/\/www.enyopharma.com\/fr\/?p=7393"},"modified":"2026-11-02T16:13:58","modified_gmt":"2026-11-02T16:13:58","slug":"8th-annual-ckd-drug-development-summit","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/8th-annual-ckd-drug-development-summit\/","title":{"rendered":"The 8th Annual CKD Drug Development Summit, Boston"},"content":{"rendered":"

17-18 mars 2026
\nBoston, USA<\/p>\n

ENYO Pharma sera pr\u00e9sent au 8\u00e8me Chronic Kidney Disease Drug Development Summit les 17 et 18 mars \u00e0 Boston. L’\u00e9v\u00e9nement dirig\u00e9 par l’industrie pharmaceutique vise \u00e0 am\u00e9liorer la fronti\u00e8re des th\u00e9rapies pr\u00e9ventives et r\u00e9g\u00e9n\u00e9ratives pour cibler efficacement les maladies r\u00e9nales et \u00e9clairer les opportunit\u00e9s d’expansion des indications dans les troubles r\u00e9naux rares.
\nJacky Vonderscher, notre CEO et cofondateur, pr\u00e9sentera \u00ab \ud835\udc00 \ud835\udc0d\ud835\udc28\ud835\udc2f\ud835\udc1e\ud835\udc25 \ud835\udc0f\ud835\udc28\ud835\udc2d\ud835\udc1e\ud835\udc27\ud835\udc2d\ud835\udc22\ud835\udc1a\ud835\udc25 \ud835\udc13\ud835\udc21\ud835\udc1e\ud835\udc2b\ud835\udc1a\ud835\udc29\ud835\udc32 \ud835\udc1f\ud835\udc28\ud835\udc2b \ud835\udc00\ud835\udc25\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d \ud835\udc12\ud835\udc32\ud835\udc27\ud835\udc1d\ud835\udc2b\ud835\udc28\ud835\udc26\ud835\udc1e \ud835\udc30\ud835\udc22\ud835\udc2d\ud835\udc21 \ud835\udc00\ud835\udc29\ud835\udc29\ud835\udc25\ud835\udc22\ud835\udc1c\ud835\udc1a\ud835\udc1b\ud835\udc22\ud835\udc25\ud835\udc22\ud835\udc2d\ud835\udc32 \ud835\udc22\ud835\udc27 \ud835\udc0c\ud835\udc2e\ud835\udc25\ud835\udc2d\ud835\udc22\ud835\udc29\ud835\udc25\ud835\udc1e \ud835\udc11\ud835\udc1a\ud835\udc2b\ud835\udc1e & \ud835\udc02\ud835\udc28\ud835\udc26\ud835\udc26\ud835\udc28\ud835\udc27 \ud835\udc11\ud835\udc1e\ud835\udc27\ud835\udc1a\ud835\udc25 \ud835\udc03\ud835\udc22\ud835\udc2c\ud835\udc1e\ud835\udc1a\ud835\udc2c\ud835\udc1e\ud835\udc2c \u00bb lors de la premi\u00e8re journ\u00e9e, le 17 mars, de 14h30 \u00e0 15h00. Il pr\u00e9sentera les programmes d\u2019ENYO Pharma, et surtout notre \ud835\udc1e\u0301\ud835\udc2d\ud835\udc2e\ud835\udc1d\ud835\udc1e \ud835\udc1c\ud835\udc25\ud835\udc22\ud835\udc27\ud835\udc22\ud835\udc2a\ud835\udc2e\ud835\udc1e \ud835\udc1d\ud835\udc1e \ud835\udc29\ud835\udc21\ud835\udc1a\ud835\udc2c\ud835\udc1e \ud835\udfd0 \ud835\udc00\ud835\udc0b\ud835\udc0f\ud835\udc04\ud835\udc12\ud835\udc13\ud835\udc11\ud835\udc08\ud835\udc00-\ud835\udfcf avec Vonafexor.<\/p>\n

https:\/\/ckd3-summit.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

17-18 mars 2026
\nBoston, USA<\/p>\n

ENYO Pharma sera pr\u00e9sent au 8\u00e8me Chronic Kidney Disease Drug Development Summit les 17 et 18 mars \u00e0 Boston. L’\u00e9v\u00e9nement dirig\u00e9 par l’industrie pharmaceutique vise \u00e0 am\u00e9liorer la fronti\u00e8re des th\u00e9rapies pr\u00e9ventives et r\u00e9g\u00e9n\u00e9ratives pour cibler efficacement les maladies r\u00e9nales et \u00e9clairer les opportunit\u00e9s d’expansion des indications dans les troubles r\u00e9naux rares.
\nJacky Vonderscher, notre CEO et cofondateur, pr\u00e9sentera \u00ab \ud835\udc00 \ud835\udc0d\ud835\udc28\ud835\udc2f\ud835\udc1e\ud835\udc25 \ud835\udc0f\ud835\udc28\ud835\udc2d\ud835\udc1e\ud835\udc27\ud835\udc2d\ud835\udc22\ud835\udc1a\ud835\udc25 \ud835\udc13\ud835\udc21\ud835\udc1e\ud835\udc2b\ud835\udc1a\ud835\udc29\ud835\udc32 \ud835\udc1f\ud835\udc28\ud835\udc2b \ud835\udc00\ud835\udc25\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d \ud835\udc12\ud835\udc32\ud835\udc27\ud835\udc1d\ud835\udc2b\ud835\udc28\ud835\udc26\ud835\udc1e \ud835\udc30\ud835\udc22\ud835\udc2d\ud835\udc21 \ud835\udc00\ud835\udc29\ud835\udc29\ud835\udc25\ud835\udc22\ud835\udc1c\ud835\udc1a\ud835\udc1b\ud835\udc22\ud835\udc25\ud835\udc22\ud835\udc2d\ud835\udc32 \ud835\udc22\ud835\udc27 \ud835\udc0c\ud835\udc2e\ud835\udc25\ud835\udc2d\ud835\udc22\ud835\udc29\ud835\udc25\ud835\udc1e \ud835\udc11\ud835\udc1a\ud835\udc2b\ud835\udc1e &<\/p>\n

Lire la suite »<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[12],"tags":[],"class_list":["post-7393","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"adm-cdubreuil","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/adm-cdubreuil\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"17-18 mars 2026 Boston, USA ENYO Pharma sera pr\u00e9sent au 8\u00e8me Chronic Kidney Disease Drug Development Summit les 17 et 18 mars \u00e0 Boston. L’\u00e9v\u00e9nement dirig\u00e9 par l’industrie pharmaceutique vise \u00e0 am\u00e9liorer la fronti\u00e8re des th\u00e9rapies pr\u00e9ventives et r\u00e9g\u00e9n\u00e9ratives pour cibler efficacement les maladies r\u00e9nales et \u00e9clairer les opportunit\u00e9s d’expansion des indications dans les troubles…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/7393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=7393"}],"version-history":[{"count":5,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/7393\/revisions"}],"predecessor-version":[{"id":7403,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/7393\/revisions\/7403"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=7393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=7393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=7393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}